𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biodistribution and imaging of 66GA-citrate and 67Ga-citrate in tumor-bearing nude mice, a comparison

✍ Scribed by I. Guenther; K. S. Pentlow; P. B. Zanzonico; R. D. Finn; D. Polycarpe; G. Kang; B. Kappel; J. O'Donoghue; J. Humm; S. M. Larson

Book ID
112132718
Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
215 KB
Volume
44
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparison of oncophilic radiopharmaceut
Comparison of oncophilic radiopharmaceuticals, *I-fibrinogen, 67Ga- citrate, 111In-bleomycin, and *I-bleomycin in tumor-bearing mice
✍ Gerald L. Denardo; Kenneth A. Krohn; Sally J. Denardo πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 556 KB

The pharmacokinetics of E7Ga-citrate, "'In-bleomycin, \*I-bleomycin, and \*Ifibrinogen were compared in a murine KHJJ tumor model in order to assess their relative potential as agents for in vivo detection of cancer. Although all four agents have been reported to be clinically efficacious, in this t

A new tumor imaging agent-111In-bleomyci
A new tumor imaging agent-111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-Bleomycin in tumor-bearing animals
✍ De-Yan Hou; Hans Hoch; Gerald S. Johnston; K. C. Tsou; Alfred E. Jones; Elizabet πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 778 KB

## Abstract We have found a new ^111^In‐bleomycin complex (BLMC), which has high affinity to tumor, does not bind to transferrin and is stable in vivo. Distribution in animals bearing glioma, hepatoma, or mammary adenocarcinoma at 48 hours showed: the ratios of tumor to blood, brain, heart, lung, l

Comparison of67Ga-citrate,111In-bleomyci
Comparison of67Ga-citrate,111In-bleomycin and99mTc-citrate in the evaluation of pulmonary lesions
✍ Praxitelis Apostolidis; Polykriti Kostaki; Nikos Hatzigeorgiou; Nikos Skambardon πŸ“‚ Article πŸ“… 1980 πŸ› Springer 🌐 English βš– 684 KB

A total of 128 patients were examined using three tumor localizing agents, 99mTc-citrate, 111In-bleomycin and 67Ga-citrate. All these patients had clinical symptoms of pulmonary disease and chest x-rays. Twenty-two patients were excluded from the original number. From the 106 remaining patients, 14